Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Werewolf Therapeutics (HOWL) Current Assets (2021 - 2025)

Werewolf Therapeutics (HOWL) has disclosed Current Assets for 5 consecutive years, with $58.6 million as the latest value for Q4 2025.

  • Quarterly Current Assets fell 48.18% to $58.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $58.6 million through Dec 2025, down 48.18% year-over-year, with the annual reading at $58.6 million for FY2025, 48.18% down from the prior year.
  • Current Assets for Q4 2025 was $58.6 million at Werewolf Therapeutics, down from $68.2 million in the prior quarter.
  • The five-year high for Current Assets was $186.4 million in Q2 2021, with the low at $58.6 million in Q4 2025.
  • Average Current Assets over 5 years is $130.1 million, with a median of $139.7 million recorded in 2022.
  • The sharpest move saw Current Assets skyrocketed 71.37% in 2022, then plummeted 48.18% in 2025.
  • Over 5 years, Current Assets stood at $161.1 million in 2021, then decreased by 12.96% to $140.2 million in 2022, then dropped by 1.31% to $138.4 million in 2023, then fell by 18.29% to $113.1 million in 2024, then plummeted by 48.18% to $58.6 million in 2025.
  • According to Business Quant data, Current Assets over the past three periods came in at $58.6 million, $68.2 million, and $80.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.